¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"staphylococcal infection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • infection
    °¨¿°
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • infection cycle
    °¨¿°°í¸®, °¨¿°»ç
  • infection focus
    °¨¿°º´ÅÍ
  • infection immunity
    °¨¿°¸é¿ª
  • infection source
    °¨¿°¿ø, Àü¿°¿ø
  • insect-borne infection
    °ïÃæ¸Å°³°¨¿°
  • intercurrent infection
    º´¹ß°¨¿°
  • latent infection
    Àẹ°¨¿°
  • laboratory infection control
    °Ë»ç½Ç°¨¿°°ü¸®
  • local infection
    ±¹¼Ò°¨¿°
  • localized infection
    ±¹¼Ò°¨¿°
  • lymphogenous infection
    ¸²ÇÁ¼º°¨¿°
  • lytic infection
    ¿ë±Õ°¨¿°
  • midpalmar space infection
    Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • inapparant infection
    ¹«Áõ»ó°¨¿°, ºÒÇö¼º°¨¿°
  • indigenous infection
    ÅäÂø°¨¿°
  • indirect infection
    °£Á¢°¨¿°
  • infection immunity
    °¨¿°¸é¿ª
  • infection route
    °¨¿°°æ·Î
  • infection source
    °¨¿°¿ø, Àü¿°¿ø
  • infection control study
    °¨¿°°ü¸®Á¶»ç
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • insect-borne infection
    °ïÃæ¸Å°³°¨¿°
  • intercurrent infection
    º´¹ß°¨¿°
  • introduced infection
    µµÀÔ°¨¿°
  • latent infection
    Àẹ°¨¿°
  • local infection
    ±¹¼Ò°¨¿°
  • localized infection
    ±¹¼Ò°¨¿°
  • lymphogenous infection
    ¸²ÇÁ°¨¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • herd infection
    Áý´Ü°¨¿°.
  • herpes genitalis infection
    Æ÷Áø¼º ¼º±â°¨¿°
  • herpes simplex infection
    ´Ü¼ø(¼º)Æ÷Áø°¨¿°
  • herpes simplex infection
    ´Ü¼øÆ÷Áø °¨¿°(¡­Êïæø)
  • hookworm infection
    ±¸Ãæ°¨¿°(ÏÉõùÊïæø).
  • hospital acquired (nosocomial) infection
    ¿ø³»°¨¿°(êÂÒ®Êïæø), º´¿ø°¨¿°.
  • hospital acquired infection
    ¿ø³»°¨¿°, º´¿ø³»°¨¿°
  • hospital infection =nosocomial i.
    ¿ø³»°¨¿°(¡­Êïæø), º´¿ø°¨¿°.
  • hospital infection =nosocomial i.
    ¿ø³»°¨¿°(¡­°¨¿°), º´¿ø°¨¿°.
  • hospital infection control
    ¿ø³»<º´¿ø>°¨¿°°ü¸®
  • huma immunodeficiency virus,follicular dendritic cell infection by
    ¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
  • inapparant infection
    ºÒÇö°¨¿°
  • inapparent infection
    ºÒÇö¼º °¨¿°.
  • indirect contact infection
    °£Á¢Á¢Ã˰¨¿° <Àü¿°>.
  • indirect infection
    °£Á¢°¨¿°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cross infection
    ±³Â÷°¨¿°(Îßó©Êïæø).
  • cryptogenic infection
    Àẹ(¼º) °¨¿°(¡­Êïæø).
  • cycle, infection
    °¨¿°ÁÖ±â
  • cytomegalovirus infection
    »çÀÌÅä¸Þ°¥·Î¹ÙÀÌ·¯½º°¨¿°(¡­Êïæø).
  • cytomegalovirus infection
    ½ÃÅä¸Þ°¥·Î¹ÙÀÌ·¯½º°¨¿°(¡­Êïæø)
  • cytomegalovirus infection
    ½ÃÅä¸Þ°¥·Î¹ÙÀÌ·¯½º°¨¿°(¡­Êïæø).
  • deep fungal infection
    ½ÉÀ缺 Áø±Õ °¨¿°
  • deep neck infection
    ½É°æºÎ °¨¿°
  • deep-seated fungal infection
    ½ÉºÎ»ç»ó±Õ°¨¿°
  • defective infection
    °á¼Õ°¨¿°
  • dental focal infection
    Ä¡¾ÆÁ߽ɰ¨¿°(¡­ñéãýÊïæø).
  • descending infection
    ÇÏÇà°¨¿°(¡­Êïæø).
  • disseminated fungal infection
    ÆÄÁ¾¼º Áø±Õ°¨¿°
  • disseminated gonococcal infection
    ÆÄÁ¾¼º ÀÓ±Õ°¨¿°
  • dormant infection
    Àẹ°¨¿°, È޸鰨¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
SSSS staphylococcal scalded skin syndrome
Staph, staph Staphylococcus, staphylococcal
STEN staphylococcal toxic epidermal necrolysis
STSS staphylococcal toxic shock syndrome
URI Upper Respiratory Infection; »ó±âµµ °¨¿°
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CRI Catheter-related infection
CMV Cytomegalovirus infection
DPI Day post infection
DGI Disseminated Gonococcal Infection
ESI Exit-site infection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neonatal infection
    ½Å»ý¾Æ °¨¿°
  • nosocomial infection
    ¿ø³» °¨¿°
    º´¿ø¿¡ °ü°èµÈ ¶Ç´Â º´¿ø¿¡¼­ ±âÀÎµÈ °¨¿°.
  • oral infection
    ±¸°­ °¨¿°, ±¸°­ °¨¿°Áõ
  • orthopoxvirus infection
    ¿À¸£Å䯸½º ¹ÙÀÌ·¯½º °¨¿°
  • parasitic infection
    ±â»ýÃæ °¨¿°
  • polymicrobial infection
    º¹¼ö ±Õ °¨¿°
  • postoperative infection
    ¼úÈÄ °¨¿°
  • primary infection
    ¿ø¹ß¼º °¨¿°, ÀÏÂ÷ °¨¿°
  • pseudomonas infection
    ³ì³ó±Õ °¨¿°, ³ì³ó±Õ °¨¿°Áõ
  • pulmonary infection
    Æó °¨¿°
  • pyogenic infection
    È­³ó¼º °¨¿°
  • recurrent herpes simplex virus infection
    Àç¹ß¼º ´Ü¼ø Æ÷Áø ¹ÙÀÌ·¯½º °¨¿°
  • route of infection
    °¨¿° °æ·Î
  • salmonella infection
    »ì¸ð³Ú¶ó °¨¿°Áõ
  • septic infection
    ÆÐÇ÷¼º °¨¿°, ÆÐÇ÷Áõ¼º °¨¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
subclinical infection <epidemiology> An infection in which symptoms are sufficiently mild or inapparent to escape diagnosis other than by positive confirmation of the ability to transmit the infection or serologically.
(05 Dec 1998)
nosocomial infection <microbiology> Hospital acquired infection: commonest are due to Staphylococcus aureus, Pseudomonas aeruginosa, E. Coli, Klebsiella pneumoniae, Serratia marcescens and Proteus mirabilis.
(18 Nov 1997)
surgical wound infection Infection occurring at the site of a surgical incision.
(12 Dec 1998)
disseminated gonococcal infection Infection from Neisseria gonorrhoea which is spread to distant parts of the body beyond the original portal of entry (usually the lower genital tract). Usually manifest by rash and arthritis.
(05 Mar 2000)
droplet infection Infection acquired through the inhalation of droplets or aerosols of saliva or sputum containing virus or other microorganisms expelled by another person during sneezing, coughing, laughing, or talking.
(05 Mar 2000)
inapparent infection Presence of infection in a host without the occurrence of recognizable symptoms or signs.
(05 Mar 2000)
infection 1. <microbiology> Invasion and multiplication of microorganisms in body tissues, which may be clinically unapparent or result in local cellular injury due to competitive metabolism, toxins, intracellular replication or antigen antibody response. The infection may remain localised, subclinical and temporary if the bodys defensive mechanisms are effective. A local infection may persist and spread by extension to become an acute, subacute or chronic clinical infection or disease state. A local infection may also become systemic when the microorganisms gain access to the lymphatic or vascular system.
2. An infectious disease.
(18 Nov 1997)
infection calculus A calculus associated with infection and/or obstruction, usually composed of struvite (magnesium ammonium phosphate).
Synonym: infection calculus.
(05 Mar 2000)
infection control Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms.
(12 Dec 1998)
infection control, dental Efforts to prevent and control the spread of infections within dental health facilities or those involving provision of dental care.
(12 Dec 1998)
infection control nurse A registered nurse with additional education in the monitoring and prevention of nosocomial infections in the client population in an agency.
Synonym: infection control nurse.
(05 Mar 2000)
infection control practitioners Physicians or other qualified individuals responsible for implementing and overseeing the policies and procedures followed by a health care facility to reduce the risk of infection to patients and staff.
(12 Dec 1998)
infection-exhaustion psychosis A psychosis following an acute infection, shock, or chronic intoxication; begins as delirium followed by pronounced mental confusion with hallucinations and unsystematised delusions, and sometimes stupor.
Synonym: febrile psychosis.
(05 Mar 2000)
infection immunity The paradoxical immune status in which resistance to reinfection coincides with the persistence of the original infection.
Synonym: concomitant immunity.
(05 Mar 2000)
infection thread In the formation of root nodules, a cellulosic tube through which Rhizobium cells can travel to reach and infect root cells.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á